62 results
8-K
ALRN
Aileron Therapeutics Inc
1 Mar 24
Departure of Directors or Certain Officers
4:07pm
, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it has regained compliance
8-K
ALRN
Aileron Therapeutics Inc
25 Jan 24
Other Events
7:00am
a systemic risk exception approved by the United States Department of the Treasury, the Federal Reserve and the FDIC. If financial institutions in which … agencies, including the Department of Justice, actively enforce the laws and regulations prohibiting the promotion of false or misleading information
8-K
EX-10.2
8z26 y1geqq
25 Jan 24
Other Events
7:00am
8-K
EX-10.3
t4pyf d22w9tx22gu
25 Jan 24
Other Events
7:00am
8-K
EX-10.1
0nhtlds7rd2cal
25 Jan 24
Other Events
7:00am
8-K
p7vqb6
10 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
8-K
EX-10.1
aflolq0uic
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-4.1
s4y4dnb
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-2.1
mlh0rxhd
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
424B5
3sqlr61ao7 jqurn
21 Jun 22
Prospectus supplement for primary offering
5:15pm
8-K
q7baah4
8 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm